HEADER TRANSCRIPTION/TRANSCRIPTION INHIBITOR 10-AUG-21 7RS4 TITLE CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (L372S, L536S) TITLE 2 IN COMPLEX WITH DMERI-8 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 6 GROUP A MEMBER 1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS ER-ALPHA, LIGAND COMPLEX, DMERI, TRANSCRIPTION-TRANSCRIPTION KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.MIN,J.C.NWACHUKWU,C.K.MIN,J.W.NJERI,S.SRINIVASAN,E.S.RANGARAJAN, AUTHOR 2 C.C.NETTLES,S.YAN,R.HOUTMAN,P.R.GRIFFIN,T.IZARD, AUTHOR 3 B.S.KATZENELLENBOGEN,J.A.KATZENELLENBOGEN,K.W.NETTLES REVDAT 3 18-OCT-23 7RS4 1 REMARK REVDAT 2 15-SEP-21 7RS4 1 JRNL REVDAT 1 08-SEP-21 7RS4 0 JRNL AUTH J.MIN,J.C.NWACHUKWU,C.K.MIN,J.W.NJERI,S.SRINIVASAN, JRNL AUTH 2 E.S.RANGARAJAN,C.C.NETTLES,V.SANABRIA GUILLEN,Y.ZIEGLER, JRNL AUTH 3 S.YAN,K.E.CARLSON,Y.HOU,S.H.KIM,S.NOVICK,B.D.PASCAL, JRNL AUTH 4 R.HOUTMAN,P.R.GRIFFIN,T.IZARD,B.S.KATZENELLENBOGEN, JRNL AUTH 5 J.A.KATZENELLENBOGEN,K.W.NETTLES JRNL TITL DUAL-MECHANISM ESTROGEN RECEPTOR INHIBITORS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 118 2021 JRNL REFN ESSN 1091-6490 JRNL PMID 34452998 JRNL DOI 10.1073/PNAS.2101657118 REMARK 2 REMARK 2 RESOLUTION. 1.78 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.78 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 90.39 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 53.0 REMARK 3 NUMBER OF REFLECTIONS : 47320 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2474 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.78 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.82 REMARK 3 REFLECTION IN BIN (WORKING SET) : 84 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 1.31 REMARK 3 BIN R VALUE (WORKING SET) : 0.2620 REMARK 3 BIN FREE R VALUE SET COUNT : 7 REMARK 3 BIN FREE R VALUE : 0.3150 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7803 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 130 REMARK 3 SOLVENT ATOMS : 205 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : -0.22000 REMARK 3 B33 (A**2) : 0.38000 REMARK 3 B12 (A**2) : 0.11000 REMARK 3 B13 (A**2) : -0.02000 REMARK 3 B23 (A**2) : -0.02000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.326 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.233 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.138 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.538 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.906 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8098 ; 0.010 ; 0.018 REMARK 3 BOND LENGTHS OTHERS (A): 7745 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10943 ; 1.382 ; 1.928 REMARK 3 BOND ANGLES OTHERS (DEGREES): 17949 ; 1.196 ; 2.936 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 972 ; 5.992 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 333 ;35.723 ;24.204 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1518 ;15.290 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 43 ;18.365 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1257 ; 0.098 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8714 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1553 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.10 REMARK 3 ION PROBE RADIUS : 0.70 REMARK 3 SHRINKAGE RADIUS : 0.70 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7RS4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-AUG-21. REMARK 100 THE DEPOSITION ID IS D_1000258500. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUL-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 - 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROCESS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49778 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.780 REMARK 200 RESOLUTION RANGE LOW (A) : 90.390 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 54.3 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.78 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDBID 2QXS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-25% PEG 3350, 200 MM MGCL2, 0.1 M REMARK 280 BIS-TRIS/HEPES/TRIS-HCL, EVAPORATION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 298 REMARK 465 LYS A 299 REMARK 465 CYS A 530 REMARK 465 LYS A 531 REMARK 465 ASN A 532 REMARK 465 HIS A 547 REMARK 465 ARG A 548 REMARK 465 LEU A 549 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 465 ILE B 298 REMARK 465 LYS B 299 REMARK 465 ARG B 300 REMARK 465 SER B 301 REMARK 465 LYS B 302 REMARK 465 LEU B 549 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 THR B 553 REMARK 465 SER B 554 REMARK 465 ILE C 298 REMARK 465 LYS C 299 REMARK 465 ARG C 300 REMARK 465 SER C 301 REMARK 465 LYS C 302 REMARK 465 HIS C 547 REMARK 465 ARG C 548 REMARK 465 LEU C 549 REMARK 465 HIS C 550 REMARK 465 ALA C 551 REMARK 465 PRO C 552 REMARK 465 THR C 553 REMARK 465 SER C 554 REMARK 465 ILE D 298 REMARK 465 LYS D 299 REMARK 465 ARG D 300 REMARK 465 SER D 301 REMARK 465 LYS D 302 REMARK 465 GLU D 419 REMARK 465 GLY D 420 REMARK 465 LEU D 462 REMARK 465 SER D 463 REMARK 465 SER D 464 REMARK 465 THR D 465 REMARK 465 LEU D 466 REMARK 465 THR D 553 REMARK 465 SER D 554 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER C 463 O HOH C 701 1.72 REMARK 500 OH TYR D 459 O HOH D 701 1.99 REMARK 500 OD2 ASP A 545 O HOH A 701 2.08 REMARK 500 O PRO C 406 O HOH C 702 2.13 REMARK 500 O HOH D 722 O HOH D 743 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OH TYR A 328 ND2 ASN B 359 1645 2.05 REMARK 500 NZ LYS A 481 OD2 ASP B 538 1655 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS C 530 CB - CA - C ANGL. DEV. = 8.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 330 114.18 -21.43 REMARK 500 ASP A 332 81.81 20.04 REMARK 500 LEU A 408 77.38 -150.93 REMARK 500 SER B 305 117.15 -35.98 REMARK 500 GLU B 339 -45.22 101.47 REMARK 500 LEU B 408 77.36 -152.04 REMARK 500 VAL B 418 121.43 72.19 REMARK 500 GLU C 330 113.39 -21.79 REMARK 500 ASP C 332 81.20 21.36 REMARK 500 LEU C 408 77.76 -152.08 REMARK 500 LYS C 531 -96.62 -33.47 REMARK 500 VAL C 533 -62.75 -101.03 REMARK 500 LEU D 408 76.48 -152.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER B 338 GLU B 339 -143.51 REMARK 500 LYS C 529 CYS C 530 139.81 REMARK 500 CYS C 530 LYS C 531 -143.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C 762 DISTANCE = 6.17 ANGSTROMS REMARK 525 HOH C 763 DISTANCE = 6.66 ANGSTROMS DBREF 7RS4 A 298 554 UNP P03372 ESR1_HUMAN 298 554 DBREF 7RS4 B 298 554 UNP P03372 ESR1_HUMAN 298 554 DBREF 7RS4 C 298 554 UNP P03372 ESR1_HUMAN 298 554 DBREF 7RS4 D 298 554 UNP P03372 ESR1_HUMAN 298 554 SEQADV 7RS4 SER A 372 UNP P03372 LEU 372 ENGINEERED MUTATION SEQADV 7RS4 SER A 536 UNP P03372 LEU 536 ENGINEERED MUTATION SEQADV 7RS4 SER B 372 UNP P03372 LEU 372 ENGINEERED MUTATION SEQADV 7RS4 SER B 536 UNP P03372 LEU 536 ENGINEERED MUTATION SEQADV 7RS4 SER C 372 UNP P03372 LEU 372 ENGINEERED MUTATION SEQADV 7RS4 SER C 536 UNP P03372 LEU 536 ENGINEERED MUTATION SEQADV 7RS4 SER D 372 UNP P03372 LEU 372 ENGINEERED MUTATION SEQADV 7RS4 SER D 536 UNP P03372 LEU 536 ENGINEERED MUTATION SEQRES 1 A 257 ILE LYS ARG SER LYS LYS ASN SER LEU ALA LEU SER LEU SEQRES 2 A 257 THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA GLU SEQRES 3 A 257 PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG PRO SEQRES 4 A 257 PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN LEU SEQRES 5 A 257 ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA LYS SEQRES 6 A 257 ARG VAL PRO GLY PHE VAL ASP LEU THR SER HIS ASP GLN SEQRES 7 A 257 VAL HIS LEU LEU GLU YCM ALA TRP LEU GLU ILE LEU MET SEQRES 8 A 257 ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY LYS SEQRES 9 A 257 LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN SEQRES 10 A 257 GLY LYS CYS VAL GLU GLY MET VAL GLU ILE PHE ASP MET SEQRES 11 A 257 LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN LEU SEQRES 12 A 257 GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE LEU SEQRES 13 A 257 LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR LEU SEQRES 14 A 257 LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU SEQRES 15 A 257 ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA LYS SEQRES 16 A 257 ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU ALA SEQRES 17 A 257 GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SER SEQRES 18 A 257 ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CYS LYS SEQRES 19 A 257 ASN VAL VAL PRO SER TYR ASP LEU LEU LEU GLU MET LEU SEQRES 20 A 257 ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 B 257 ILE LYS ARG SER LYS LYS ASN SER LEU ALA LEU SER LEU SEQRES 2 B 257 THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA GLU SEQRES 3 B 257 PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG PRO SEQRES 4 B 257 PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN LEU SEQRES 5 B 257 ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA LYS SEQRES 6 B 257 ARG VAL PRO GLY PHE VAL ASP LEU THR SER HIS ASP GLN SEQRES 7 B 257 VAL HIS LEU LEU GLU YCM ALA TRP LEU GLU ILE LEU MET SEQRES 8 B 257 ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY LYS SEQRES 9 B 257 LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN SEQRES 10 B 257 GLY LYS CYS VAL GLU GLY MET VAL GLU ILE PHE ASP MET SEQRES 11 B 257 LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN LEU SEQRES 12 B 257 GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE LEU SEQRES 13 B 257 LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR LEU SEQRES 14 B 257 LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU SEQRES 15 B 257 ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA LYS SEQRES 16 B 257 ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU ALA SEQRES 17 B 257 GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SER SEQRES 18 B 257 ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CYS LYS SEQRES 19 B 257 ASN VAL VAL PRO SER TYR ASP LEU LEU LEU GLU MET LEU SEQRES 20 B 257 ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 C 257 ILE LYS ARG SER LYS LYS ASN SER LEU ALA LEU SER LEU SEQRES 2 C 257 THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA GLU SEQRES 3 C 257 PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG PRO SEQRES 4 C 257 PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN LEU SEQRES 5 C 257 ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA LYS SEQRES 6 C 257 ARG VAL PRO GLY PHE VAL ASP LEU THR SER HIS ASP GLN SEQRES 7 C 257 VAL HIS LEU LEU GLU YCM ALA TRP LEU GLU ILE LEU MET SEQRES 8 C 257 ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY LYS SEQRES 9 C 257 LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN SEQRES 10 C 257 GLY LYS CYS VAL GLU GLY MET VAL GLU ILE PHE ASP MET SEQRES 11 C 257 LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN LEU SEQRES 12 C 257 GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE LEU SEQRES 13 C 257 LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR LEU SEQRES 14 C 257 LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU SEQRES 15 C 257 ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA LYS SEQRES 16 C 257 ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU ALA SEQRES 17 C 257 GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SER SEQRES 18 C 257 ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CYS LYS SEQRES 19 C 257 ASN VAL VAL PRO SER TYR ASP LEU LEU LEU GLU MET LEU SEQRES 20 C 257 ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 D 257 ILE LYS ARG SER LYS LYS ASN SER LEU ALA LEU SER LEU SEQRES 2 D 257 THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA GLU SEQRES 3 D 257 PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG PRO SEQRES 4 D 257 PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN LEU SEQRES 5 D 257 ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA LYS SEQRES 6 D 257 ARG VAL PRO GLY PHE VAL ASP LEU THR SER HIS ASP GLN SEQRES 7 D 257 VAL HIS LEU LEU GLU YCM ALA TRP LEU GLU ILE LEU MET SEQRES 8 D 257 ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY LYS SEQRES 9 D 257 LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN SEQRES 10 D 257 GLY LYS CYS VAL GLU GLY MET VAL GLU ILE PHE ASP MET SEQRES 11 D 257 LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN LEU SEQRES 12 D 257 GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE LEU SEQRES 13 D 257 LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR LEU SEQRES 14 D 257 LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU SEQRES 15 D 257 ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA LYS SEQRES 16 D 257 ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU ALA SEQRES 17 D 257 GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SER SEQRES 18 D 257 ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CYS LYS SEQRES 19 D 257 ASN VAL VAL PRO SER TYR ASP LEU LEU LEU GLU MET LEU SEQRES 20 D 257 ASP ALA HIS ARG LEU HIS ALA PRO THR SER MODRES 7RS4 YCM A 381 CYS MODIFIED RESIDUE MODRES 7RS4 YCM B 381 CYS MODIFIED RESIDUE MODRES 7RS4 YCM C 381 CYS MODIFIED RESIDUE MODRES 7RS4 YCM D 381 CYS MODIFIED RESIDUE HET YCM A 381 10 HET YCM B 381 10 HET YCM C 381 10 HET YCM D 381 10 HET 7I0 A 601 32 HET CL B 601 1 HET 7I0 B 602 32 HET 7I0 C 601 32 HET CL D 601 1 HET 7I0 D 602 32 HETNAM YCM S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE HETNAM 7I0 (2E)-3-{4-[(1E)-2-(2-CHLORO-4-FLUOROPHENYL)-1-(2H- HETNAM 2 7I0 INDAZOL-5-YL)BUT-1-EN-1-YL]PHENYL}PROP-2-ENOIC ACID HETNAM CL CHLORIDE ION HETSYN YCM CYSTEINE-S-ACETAMIDE FORMUL 1 YCM 4(C5 H10 N2 O3 S) FORMUL 5 7I0 4(C26 H20 CL F N2 O2) FORMUL 6 CL 2(CL 1-) FORMUL 11 HOH *205(H2 O) HELIX 1 AA1 SER A 305 LEU A 310 5 6 HELIX 2 AA2 THR A 311 ALA A 322 1 12 HELIX 3 AA3 SER A 338 ARG A 363 1 26 HELIX 4 AA4 THR A 371 MET A 396 1 26 HELIX 5 AA5 ARG A 412 LYS A 416 1 5 HELIX 6 AA6 GLY A 420 ASN A 439 1 20 HELIX 7 AA7 GLN A 441 SER A 456 1 16 HELIX 8 AA8 GLY A 457 PHE A 461 5 5 HELIX 9 AA9 THR A 465 ALA A 493 1 29 HELIX 10 AB1 THR A 496 LYS A 529 1 34 HELIX 11 AB2 SER A 536 ALA A 546 1 11 HELIX 12 AB3 SER B 305 LEU B 310 5 6 HELIX 13 AB4 THR B 311 ALA B 322 1 12 HELIX 14 AB5 SER B 341 ARG B 363 1 23 HELIX 15 AB6 THR B 371 SER B 395 1 25 HELIX 16 AB7 ARG B 412 LYS B 416 1 5 HELIX 17 AB8 GLY B 420 MET B 438 1 19 HELIX 18 AB9 GLN B 441 SER B 456 1 16 HELIX 19 AC1 GLY B 457 PHE B 461 5 5 HELIX 20 AC2 THR B 465 ALA B 493 1 29 HELIX 21 AC3 THR B 496 MET B 528 1 33 HELIX 22 AC4 SER B 536 ARG B 548 1 13 HELIX 23 AC5 SER C 305 LEU C 310 5 6 HELIX 24 AC6 THR C 311 ALA C 322 1 12 HELIX 25 AC7 SER C 338 ARG C 363 1 26 HELIX 26 AC8 THR C 371 SER C 395 1 25 HELIX 27 AC9 ARG C 412 LYS C 416 1 5 HELIX 28 AD1 GLY C 420 MET C 438 1 19 HELIX 29 AD2 GLN C 441 SER C 456 1 16 HELIX 30 AD3 GLY C 457 PHE C 461 5 5 HELIX 31 AD4 THR C 465 ALA C 493 1 29 HELIX 32 AD5 THR C 496 LYS C 529 1 34 HELIX 33 AD6 SER C 536 ALA C 546 1 11 HELIX 34 AD7 SER D 305 LEU D 310 5 6 HELIX 35 AD8 THR D 311 ALA D 322 1 12 HELIX 36 AD9 PRO D 336 ALA D 340 5 5 HELIX 37 AE1 SER D 341 ARG D 363 1 23 HELIX 38 AE2 THR D 371 SER D 395 1 25 HELIX 39 AE3 ARG D 412 LYS D 416 1 5 HELIX 40 AE4 VAL D 422 MET D 438 1 17 HELIX 41 AE5 GLN D 441 SER D 456 1 16 HELIX 42 AE6 GLY D 457 PHE D 461 5 5 HELIX 43 AE7 SER D 468 ALA D 493 1 26 HELIX 44 AE8 THR D 496 MET D 528 1 33 HELIX 45 AE9 SER D 536 LEU D 549 1 14 SHEET 1 AA1 2 LYS A 401 ALA A 405 0 SHEET 2 AA1 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 AA2 2 LYS B 401 ALA B 405 0 SHEET 2 AA2 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 SHEET 1 AA3 2 LYS C 401 ALA C 405 0 SHEET 2 AA3 2 LEU C 408 ASP C 411 -1 O LEU C 410 N LEU C 402 SHEET 1 AA4 2 LYS D 401 ALA D 405 0 SHEET 2 AA4 2 LEU D 408 ASP D 411 -1 O LEU D 410 N LEU D 402 LINK C GLU A 380 N YCM A 381 1555 1555 1.34 LINK C YCM A 381 N ALA A 382 1555 1555 1.34 LINK C GLU B 380 N YCM B 381 1555 1555 1.33 LINK C YCM B 381 N ALA B 382 1555 1555 1.34 LINK C GLU C 380 N YCM C 381 1555 1555 1.34 LINK C YCM C 381 N ALA C 382 1555 1555 1.34 LINK C GLU D 380 N YCM D 381 1555 1555 1.34 LINK C YCM D 381 N ALA D 382 1555 1555 1.35 CISPEP 1 ARG A 335 PRO A 336 0 -0.40 CISPEP 2 ARG C 335 PRO C 336 0 -1.24 CRYST1 53.087 58.816 93.709 86.88 75.21 63.40 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018837 -0.009434 -0.005638 0.00000 SCALE2 0.000000 0.019015 0.001320 0.00000 SCALE3 0.000000 0.000000 0.011063 0.00000